NYSE:CHE - Chemed Stock Price, Forecast & News

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Chemed announced a quarterly dividend on Friday, November 1st. Investors of record on Monday, November 11th will be given a dividend of $0.32 per share on Monday, December 2nd. This represents a $1.28 annualized dividend and a dividend yield of 0.25%. The ex-dividend date is Thursday, November 7th. View Chemed's Dividend History.

Chemed announced that its Board of Directors has authorized a stock repurchase plan on Wednesday, March 7th 2018, which allows the company to buyback $150,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Shares buyback plans are often an indication that the company's board of directors believes its shares are undervalued.

Chemed Co. (NYSE:CHE) posted its quarterly earnings results on Tuesday, February, 18th. The company reported $4.22 EPS for the quarter, topping the consensus estimate of $4.09 by $0.13. The company had revenue of $522.30 million for the quarter, compared to analysts' expectations of $524.20 million. Chemed had a net margin of 11.14% and a return on equity of 35.06%. The company's revenue was up 14.2% on a year-over-year basis. During the same quarter last year, the business earned $3.35 EPS. View Chemed's Earnings History.

Chemed is scheduled to release their next quarterly earnings announcement on Monday, May 4th 2020. View Earnings Estimates for Chemed.

Chemed updated its FY20 earnings guidance on Tuesday, February, 18th. The company provided earnings per share (EPS) guidance of $16.20-16.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $15.63.

4 analysts have issued 12-month price targets for Chemed's shares. Their forecasts range from $405.00 to $535.00. On average, they anticipate Chemed's share price to reach $482.50 in the next twelve months. This suggests that the stock has a possible downside of 5.3%. View Analyst Price Targets for Chemed.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.

Media headlines about CHE stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Chemed earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Chemed.

Some companies that are related to Chemed include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), BioScrip (BIOS), Davita (DVA), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include Home Depot (HD), Altria Group (MO), AT&T (T), AbbVie (ABBV), CVS Health (CVS), Chevron (CVX), Walt Disney (DIS), Enterprise Products Partners (EPD), Occidental Petroleum (OXY) and Boeing (BA).

Chemed's stock is owned by a number of of retail and institutional investors. Top institutional investors include Acadian Asset Management LLC (3.26%), FMR LLC (2.83%), State Street Corp (2.49%), Riverbridge Partners LLC (2.29%), Investec Asset Management LTD (1.70%) and Renaissance Technologies LLC (1.23%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Institutional Ownership Trends for Chemed.

CHE stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Russell Investments Group Ltd., Barclays PLC, State Street Corp, Goldman Sachs Group Inc., Prudential Financial Inc., State of Tennessee Treasury Department and Smith Asset Management Group LP. Company insiders that have sold Chemed company stock in the last year include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Insider Buying and Selling for Chemed.

CHE stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Teacher Retirement System of Texas, Loomis Sayles & Co. L P, Marshall Wace North America L.P., Investec Asset Management LTD, Thrivent Financial for Lutherans and Bank of America Corp DE. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CHE stock can currently be purchased for approximately $509.65.

Chemed has a market capitalization of $8.16 billion and generates $1.78 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $11.93 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.

The official website for Chemed is http://www.chemed.com/.

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.